Navigation Links
Roberta A. Pagon receives lifetime award in genetics from March of Dimes
Date:3/26/2009

TAMPA, F.L. MARCH 27, 2009 The founder of a public database that helps doctors analyze the usefulness of genetic tests in making medical decisions is the 2009 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.

Roberta "Bonnie" Pagon, MD, professor of Pediatrics at the University of Washington School of Medicine in Seattle, developed the Web site genetests.org in 1992 and today is the principal investigator of this National Institutes of Health-funded program. Dr. Pagon has been a medical geneticist for more than 25 years and also is adjunct professor in the University's departments of ophthalmology and medicine. Her clinical work focuses on genetic eye diseases and syndrome delineation reviewing the symptoms of patients who do not have a diagnosis to see if there might be a new disorder.

"Dr. Pagon is responsible for sharing critical information about the diagnosis and management of genetic diseases with physicians worldwide," said Michael Katz, MD, March of Dimes senior vice president of Research and Global Programs, who presented the award today to Dr. Pagon at the Annual Clinical Genetics Meeting of the American College of Medical Genetics held here. "She is a pioneer in the field of medical genetics, and the March of Dimes is pleased to honor her."

In its 15-year history, genetests.org has grown to become an important international resource for genetic testing information. The site promotes the appropriate use of genetic testing in patient treatment and personal decision-making. For her work on GeneTests, Dr. Pagon previously received the American Society of Human Genetics 2006 Education Award.

Dr. Pagon also is a consultant to the Regional Genetics Program of Washington State and an attending physician in the Children's Hospital and Regional Medical Center Genetics Clinic. She is a member of the board of directors of the American Board of Medical Genetics (ABMG) and a member of the Clinical Practice Committee of the American College of Medical Genetics (ACMG).

She is the review board coordinator for the Collaboration, Education, and Test Translation (CETT) Program, which promotes the collaborative development of new tests for rare genetic diseases for use by doctors and patients, and supports the collection and storage of genetic test results so they can be used to guide new research.


'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

Related biology news :

1. The University of Miami receives grants from Royal Caribbean Cruises Ltd.s Ocean Fund
2. Rensselaer receives more than $2 million from New York State to fund stem cell research
3. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
4. Dr. King receives IADR Craniofacial Biology Research Award
5. Christopher McCulloch receives the IADR Research in Oral Biology Award
6. NJIT receives $20,000 grant from Horizon Foundation to promote teen health
7. Oxfords Dr. Rosalind Rickaby receives 2009 Rosenstiel Award
8. Queens receives $9.1 million to establish National Center of Excellence in green chemistry
9. Little Salt Spring underwater archeological site in Florida receives new funding
10. Biophysical sciences program receives $2 million training grant
11. Biologist receives the 2008 AAAS Public Understanding of Science and Technology Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... ... value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic ... Symposium. Using molecular test results from tumors with previously documented positive, negative, ...
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will build ... popularity of US Single Day Events (SDE) to organize a multiple-day US conference. ... Raleigh, NC. Topics of the pharmaceutical and life sciences industry will cover industry ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only ... a beautiful technology experience. All three tenets were on display at the 2nd Annual ... from over 40 sponsor, CRO and site organizations to discuss innovation and the future ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved chemistry, ... in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
Breaking Biology Technology: